Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 33
Filtrar
Más filtros

País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
Complement Ther Med ; 54: 102549, 2020 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-33183667

RESUMEN

OBJECTIVES: Patients with cancer frequently use botanical medications. The concomitant use of such medications by patients on commercial trials has not been well-described, despite the importance of these trials for evaluating the safety and efficacy of new agents. We sought to describe the use of botanical medications taken by patients with prostate cancer enrolled on global commercial trials. DESIGN: Retrospective study. SETTING: Regulatory repository of commercial clinical trial data. INTERVENTIONS: Anti-cancer therapy. MAIN OUTCOME MEASURES: Botanical and medication use data were pooled across six international commercial randomized trials for metastatic prostate cancer with detailed information on medication and indications. Botanical products were considered to have potential for drug interaction if they led to a change in drug exposure in human trials. Potential for interaction was ascertained by PubMed review. Descriptive statistics were used for analysis. RESULTS: Of 7318 enrolled patients, 700 (10 %) reported botanical use at any time and 653 (9%) reported use of botanical products while on trial. Nearly half of botanical product types were not classified by plant (43 %). The highest proportion of botanical use was among patients in Asian countries (32 %), followed by patients in North America (13 %). Eighty-six different types of botanical products were used; of these, nineteen had a patient-reported anti-cancer indication. CONCLUSIONS: Botanical medicine use among patients with prostate cancer in commercial trials is moderate, although it varies by region. Practitioners should be aware of the use of botanical interventions in a clinical trial context.


Asunto(s)
Terapias Complementarias/métodos , Terapias Complementarias/estadística & datos numéricos , Fitoterapia/métodos , Fitoterapia/estadística & datos numéricos , Preparaciones de Plantas , Neoplasias de la Próstata/tratamiento farmacológico , Quimioterapia Combinada , Humanos , Masculino , Ensayos Clínicos Controlados Aleatorios como Asunto , Estudios Retrospectivos
2.
Beijing Da Xue Xue Bao Yi Xue Ban ; 51(6): 1159-1164, 2019 Dec 18.
Artículo en Chino | MEDLINE | ID: mdl-31848522

RESUMEN

OBJECTIVE: To evaluate the safety and efficacy of the seven-step two-lobe holmium laser enucleation of the prostate (HoLEP) technique with low power laser device, and to introduce the detailed operating procedures, key points, short-term outcomes of this modified HoLEP technique. METHODS: From March 2016 to November 2017, 90 patients underwent HoLEP in Peking University Third Hospital. The patients were divided into two groups: high-power group (32 patients) were performed with traditional Gilling's three-lobe enucleation using high power (90 W) laser; Low-power group (58 patients) were performed with seven-step two-lobe enucleation using low power (40 W) laser. The main steps of the low power seven-step two-lobe HoLEP phase included: (1) The identification of the correct plane between adenoma and capsule at 5 and 7 o'clock laterally to the veru montanum; (2) The connection of the bilateral plane by making a adenoma incision at the proximal point of veru montanum; (3) The extension of the dorsal plane under the whole three lobes between adenoma and capsule towards the bladder neck; (4) The separation of the middle lobe from two lateral lobes by making two retrograde incisions separately from apex 5 and 7 o'clock towards the bladder neck; (5) The enucleation of the middle lobe adenoma by extending the dorsal plane through into the bladder; (6) The prevention of the apex mucosa by making a circle incision at the apex of the prostate; (7) The en-bloc enucleation of the two lateral lobe adenomas by extending the lateral and ventral plane between adenoma and capsule from 5 and 7 o'clock to 12 o'clock conjunction and through into the bladder. RESULTS: The mean patient age was (66.25±5.37) years vs. (68.00±5.18) years; The mean body mass indexes were (24.13±4.06) kg/m2 vs. (24.57±3.50) kg/m2; The mean prostate specific antigen values were (3.23±2.47) µg/L vs. (6.00±6.09) µg/L; The average prostatic volumes evaluated by ultrasound was (49.03±20.63) mL vs. (67.55±36.97) mL. There was no significant difference between the two groups. Furthermore, there were no significant differences in terms of perioperative and follow up data, including operative time; enucleation efficiencies; hemoglobin decrease; blood sodium and potassiumthe change postoperatively; catheterization duration and hospital stay; the international prostate symptom scores and quality of life scores pre- and post-operatively. There was 1 transurethral resection of the prostate (TURP) conversion in high-power group and 1 transfusion in low-power group during the operations. The follow-up one month after operation showed no severe stress incontinence in both the groups, whereas 3 cases ejaculatory dysfunctions in high-power group versus 1 case in low-power group were observed; Other surgeryrelated complications included: 2 cases postoperative hemorrhage (Clavien II and Clavien IIIb) in high-power group, 2 cases postoperative temperature more than 38 °C (Clavien I) and 1 case dysuria following catheter removal (Clavien I) in low-power group. CONCLUSION: Low power laser device can be applied safe and effectively for HoLEP procedure using the seven-step two-lobe HoLEP technique. The outcomes comparable with high power laser HoLEP can be achieved.


Asunto(s)
Terapia por Láser , Láseres de Estado Sólido , Hiperplasia Prostática , Resección Transuretral de la Próstata , Holmio , Humanos , Masculino , Hiperplasia Prostática/cirugía , Calidad de Vida , Resultado del Tratamiento
3.
Braz J Med Biol Res ; 51(3): e6853, 2018 Jan 11.
Artículo en Inglés | MEDLINE | ID: mdl-29340523

RESUMEN

Glutathione synthetase deficiency (GSSD) is a rare inborn error of glutathione metabolism with autosomal recessive inheritance. The severe form of the disease is characterized by acute metabolic acidosis, usually present in the neonatal period with hemolytic anemia and progressive encephalopathy. A case of a male newborn infant who had severe metabolic acidosis with high anion gap, hemolytic anemia, and hyperbilirubinemia is reported. A high level of 5-oxoproline was detected in his urine and a diagnosis of generalized GSSD was made. DNA sequence analysis revealed the infant to be compound heterozygous with two mutations, c.738dupG in exon 8 of GSS gene resulting in p.S247fs and a repetitive sequence in exon 3 of GSS gene. Treatment after diagnosis of GSSD included supplementation with antioxidants and oral sodium hydrogen bicarbonate. However, he maintained a variable degree of metabolic acidosis and succumbed shortly after his parents requested discontinuation of therapy because of dismal prognosis and medical futility when he was 18 days old.


Asunto(s)
Errores Innatos del Metabolismo de los Aminoácidos/genética , Glutatión Sintasa/deficiencia , Mutación , Acidosis/etiología , Errores Innatos del Metabolismo de los Aminoácidos/metabolismo , Ácido Glutámico/análisis , Glutatión Sintasa/genética , Glutatión Sintasa/metabolismo , Humanos , Recién Nacido , Masculino , Piroglutamato Hidrolasa/deficiencia , Piroglutamato Hidrolasa/genética , Análisis de Secuencia de ADN/métodos
4.
Braz. j. med. biol. res ; 51(3): e6853, 2018. tab, graf
Artículo en Inglés | LILACS | ID: biblio-889048

RESUMEN

Glutathione synthetase deficiency (GSSD) is a rare inborn error of glutathione metabolism with autosomal recessive inheritance. The severe form of the disease is characterized by acute metabolic acidosis, usually present in the neonatal period with hemolytic anemia and progressive encephalopathy. A case of a male newborn infant who had severe metabolic acidosis with high anion gap, hemolytic anemia, and hyperbilirubinemia is reported. A high level of 5-oxoproline was detected in his urine and a diagnosis of generalized GSSD was made. DNA sequence analysis revealed the infant to be compound heterozygous with two mutations, c.738dupG in exon 8 of GSS gene resulting in p.S247fs and a repetitive sequence in exon 3 of GSS gene. Treatment after diagnosis of GSSD included supplementation with antioxidants and oral sodium hydrogen bicarbonate. However, he maintained a variable degree of metabolic acidosis and succumbed shortly after his parents requested discontinuation of therapy because of dismal prognosis and medical futility when he was 18 days old.


Asunto(s)
Humanos , Masculino , Recién Nacido , Errores Innatos del Metabolismo de los Aminoácidos/genética , Glutatión Sintasa/deficiencia , Mutación , Acidosis/etiología , Errores Innatos del Metabolismo de los Aminoácidos/metabolismo , Ácido Glutámico/análisis , Glutatión Sintasa/genética , Glutatión Sintasa/metabolismo , Piroglutamato Hidrolasa/deficiencia , Piroglutamato Hidrolasa/genética , Análisis de Secuencia de ADN/métodos
5.
Faraday Discuss ; 202: 31-42, 2017 09 21.
Artículo en Inglés | MEDLINE | ID: mdl-28653735

RESUMEN

Mango peel is the major by-product of mango processing, and compromises 7-24% of the total mango weight. In this study, pectin was extracted from mango peel waste by using subcritical water extraction (SWE) in the absence of mineral acid. A highest yield of 18.34% was achieved from the Kesar variety and the pectin was characterised using ATR-IR spectroscopy, TGA and 13C solid-state NMR spectroscopy to confirm the structure. The degree of esterification (DE) of the pectin was analysed with both titrimetry and 13C solid-state NMR spectroscopy, and a high DE (>70%) was observed for all three varieties (Keitt, Sindhri and Kesar). This is the first report on acid-free subcritical water extraction of pectin from mango peel, which provides a green route for the valorisation of mango peel waste and contributes to a source of biobased materials and chemicals for a sustainable 21st century.


Asunto(s)
Abastecimiento de Alimentos , Mangifera/química , Pectinas/aislamiento & purificación , Agua/química , Pectinas/química , Residuos
6.
Braz J Med Biol Res ; 50(6): e5954, 2017 May 15.
Artículo en Inglés | MEDLINE | ID: mdl-28513773

RESUMEN

Salvianolic acid B (SAB) is one the major phytocomponents of Radix Salvia miltiorrhiza and exhibit numerous health promoting properties. The objective of the current study was to examine whether SAB exerts a renoprotective effect by attenuating oxidative stress and inflammatory response through activating phosphatidylinositol 3-kinase/serine-threonine kinase B (PI3K/Akt) signaling pathway in a renal ischemic reperfusion rat model. Forty Sprague-Dawley male rats (250-300 g) were obtained and split into four groups with ten rats in each group. The right kidney of all rats was removed (nephrectomy). The rats of the Control group received only saline (occlusion) and served as a sham control group, whereas rats subjected to ischemic reperfusion (IR) insult by clamping the left renal artery served as a postitive control group. The other 2 groups of rats were pretreated with SAB (20 and 40 mg·kg-1·day-1) for 7 days prior IR induction and served as treatment groups (SAB 20+IR; SAB 40+IR). Renal markers creatinine (Cr) and blood urea nitrogen (BUN) were significantly lower in the groups that received SAB. Pretreatment with SAB appears to attenuate oxidative stress by suppressing the production of lipid peroxidation products like malondialdehyde as well as elevating antioxidant activity. The concentration of inflammatory markers and neutrophil infiltration (myeloperoxidase) were significantly decreased. Meanwhile, PI3K protein expression and pAkt/Akt ratio were significantly upregulated upon supplementation with SAB, indicating its renoprotective activity. Taken together, these results indicate that SAB can therapeutically alleviate oxidative stress and inflammatory process via modulating PI3K/Akt signaling pathway and probably ameliorate renal function and thus act as a renoprotective agent.


Asunto(s)
Benzofuranos/farmacología , Medicamentos Herbarios Chinos/farmacología , Estrés Oxidativo/efectos de los fármacos , Fosfatidilinositol 3-Quinasas/metabolismo , Sustancias Protectoras/farmacología , Proteínas Proto-Oncogénicas c-akt/metabolismo , Daño por Reperfusión/tratamiento farmacológico , Animales , Nitrógeno de la Urea Sanguínea , Creatinina/metabolismo , Inflamación/metabolismo , Riñón/patología , Peroxidación de Lípido/efectos de los fármacos , Masculino , Peroxidasa/efectos de los fármacos , Ratas Sprague-Dawley , Daño por Reperfusión/metabolismo , Transducción de Señal
7.
J Anim Sci ; 93(11): 5291-303, 2015 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-26641049

RESUMEN

Two experiments were conducted, under typical commercial swine production conditions, to determine effects of dietary arginine supplementation during early gestation on the performance of gilts and sows. In Exp. 1, between d 1 and 30 of gestation, 62 Landrace gilts and 113 sows consumed a corn- and soybean meal-based diet supplemented with 1.3% -arginine HCl or 2.2% -alanine. Total numbers of piglets born ( < 0.05) and born alive ( < 0.01) per litter and litter birth weights of piglets born ( < 0.05) and born alive ( < 0.05) were increased in the arginine group compared with the control. In Exp. 2, 155 multiparous Landrace sows received 1.3% -arginine HCl supplementation between d 1 and 14 (T2; = 41), d 15 and 30 (T3; = 40), or d 1 and 30 (T4; = 37), whereas the control group received 2.2% -alanine supplementation between d 1 and 30 (T1; = 37). Blood samples were randomly obtained from 6 sows per group on d 1, 14, and 28 of gestation to determine plasma concentrations of AA and related metabolites. Total numbers of piglets born ( = 0.084) and born alive ( = 0.080) per litter tended to be higher for sows supplemented with arginine between d 1 and 14 of gestation (T2) than for control sows (T1). Concentrations of arginine and nitric oxide metabolites were greater ( < 0.05) in T4 compared with T1 and T3 on d 14 of gestation and were also greater in T4 compared with T1 and T2 on d 28 of gestation. Plasma concentrations of spermidine ( < 0.001) were increased in T3 and T4 compared with T1 and T2 on d 28. These results indicate that dietary arginine supplementation during early gestation improves the reproductive performance of gilts and sows, possibly via nitric oxide and polyamine-dependent mechanisms.


Asunto(s)
Arginina/farmacología , Peso al Nacer/efectos de los fármacos , Suplementos Dietéticos , Tamaño de la Camada/efectos de los fármacos , Porcinos/fisiología , Alimentación Animal/análisis , Fenómenos Fisiológicos Nutricionales de los Animales , Animales , Arginina/administración & dosificación , Dieta/veterinaria , Femenino , Fenómenos Fisiologicos Nutricionales Maternos , Paridad , Parto , Plasma , Embarazo , Reproducción/efectos de los fármacos , Porcinos/sangre
8.
Methods Find Exp Clin Pharmacol ; 31(4): 231-6, 2009 May.
Artículo en Inglés | MEDLINE | ID: mdl-19557200

RESUMEN

The present study investigated whether dl-praeruptorin (Pd-Ia) prevents endothelin-1 (ET-1)-induced cardiomyocyte hypertrophy and the potential pathways that underlie such an effect. We assessed cardiomyocyte surface area, protein synthesis, the expression of Bax/Bcl2 and Jun genes, the expression of atrial natriuretic factor (ANF) and Ca2+/calmodulin-dependent kinase II (CaMK-II) activity in cultured neonatal rat ventricular cardiomyocytes with ET-1-induced hypertrophy. It was found that Pd-Ia decreased the surface area and protein synthesis rate in cardiomyocytes exposed to ET-1. Additionally, the expression of Bcl2 and Bax was increased in both the ET-1-exposed and Pd-Ia+ET- 1-treated groups compared with the control group, although this was not significant. In cardiomyocytes incubated with ET-1, the expression of ANF (Nppa) significantly increased relative to the control and Pd-Ia groups. The expression of Jun significantly increased in cardiomyocytes incubated with ET-1, but not in the Pd-Ia group, where Jun levels were similar to those found for the control group. Moreover, it was found that Pd-Ia inhibited the ET-1-induced increase in intracellular Ca(2+) concentration. The results showed that Pd-Ia could conceivably be an effective therapeutic drug for treating the contractile defects associated with cardiac hypertrophy and failure. This activity may be associated with its Ca2+-antagonist effect and modulation of the expression of immediate-early genes that play important roles in the mitogen-activated protein (MAP) kinase pathway.


Asunto(s)
Cardiomegalia/tratamiento farmacológico , Cumarinas/farmacología , Medicamentos Herbarios Chinos/farmacología , Miocitos Cardíacos/efectos de los fármacos , Animales , Calcio/antagonistas & inhibidores , Cardiomegalia/metabolismo , Células Cultivadas , Endotelina-1/toxicidad , Regulación de la Expresión Génica/efectos de los fármacos , Ventrículos Cardíacos/citología , Contracción Miocárdica/efectos de los fármacos , Miocitos Cardíacos/metabolismo , Proteínas Proto-Oncogénicas c-bcl-2/efectos de los fármacos , Proteínas Proto-Oncogénicas c-bcl-2/genética , Proteínas Proto-Oncogénicas c-jun/efectos de los fármacos , Proteínas Proto-Oncogénicas c-jun/genética , Ratas , Ratas Sprague-Dawley , Proteína X Asociada a bcl-2/efectos de los fármacos , Proteína X Asociada a bcl-2/genética
9.
Artículo en Inglés | MEDLINE | ID: mdl-17952756

RESUMEN

The dissipation behaviour of endosulfan in dry made-tea leaves of oolong and green tea was compared to establish whether there was any difference in dissipation rates between the two teas. The dissipation of endosulfan in oolong and green tea corresponded with a first-order kinetics curve. The average half-life of endosulfan (n = 12) was 1.60 +/- 0.44 days in green tea and 2.01 +/- 0.55 days in oolong tea, showing a statistically significant difference, and indicating that the dissipation of the pesticide was significantly slower in oolong tea than that in green tea. Although the initial levels of residual endosulfan were lower in oolong tea, due to the slower dissipation rate, the residues 5-7 days after application were higher in oolong than in green tea. It is suggested that the minimum interval between endosulfan application and tea leaf harvesting is 7 days for green tea and 10 days for oolong tea in the case where the maximum residue limit of endosulfan in made-tea is fixed as 10 mg kg(-1).


Asunto(s)
Endosulfano/análisis , Contaminación de Alimentos/análisis , Manipulación de Alimentos/métodos , Insecticidas/análisis , Residuos de Plaguicidas/análisis , Té/química , Endosulfano/química , Semivida , Insecticidas/química , Concentración Máxima Admisible , Residuos de Plaguicidas/química
10.
Digestion ; 73(2-3): 101-6, 2006.
Artículo en Inglés | MEDLINE | ID: mdl-16788304

RESUMEN

AIM: To determine the antibiotic susceptibility of Helicobacter pylori and evaluate the efficacy of a clarithromycin-based triple therapy in relation to antibiotic resistance. METHODS: Consecutive patients referred for upper endoscopy due to dyspeptic symptoms were recruited. Gastric biopsies were obtained for the CLO test, histology and culture. Antibiotic susceptibility was assessed by the E-test. Patients with H. pylori infection received rabeprazole 20 mg, clarithromycin 500 mg, and amoxicillin 1,000 mg, all twice daily for 7 days. RESULTS: Of 234 patients recruited, 124 were H. pylori-positive and culture was successful in 102 patients. The updated prevalences of resistance to clarithromycin, amoxicillin and metronidazole were 7.8, 0 and 39.2%, respectively. A total of 86 patients received 1-week triple therapy with rabeprazole 20 mg, clarithromycin 500 mg, and amoxicillin 1,000 mg, all twice daily, and 81 patients attended the follow-up test. Eradication rates by per-protocol and intention-to-treat analysis were 92.6 and 87.2%, respectively. The eradication rate by per protocol was significantly higher in patients with clarithromycin-susceptible strains than in those with clarithromycin-resistant strains (98.6 vs. 28.6%, p < 0.001). CONCLUSION: Clarithromycin resistance reduces the clinical efficacy of clarithromycin-based triple therapy. However, due to the low prevalence of clarithromycin resistance, clarithromycin-based therapy is still the first choice for clinical use.


Asunto(s)
Antibacterianos/uso terapéutico , Claritromicina/uso terapéutico , Farmacorresistencia Bacteriana , Infecciones por Helicobacter/tratamiento farmacológico , Helicobacter pylori , 2-Piridinilmetilsulfinilbencimidazoles/uso terapéutico , Adulto , Anciano , Amoxicilina/uso terapéutico , Antiulcerosos/uso terapéutico , Biopsia , Pruebas Respiratorias , Distribución de Chi-Cuadrado , Quimioterapia Combinada , Endoscopía Gastrointestinal , Femenino , Helicobacter pylori/aislamiento & purificación , Hong Kong , Humanos , Masculino , Pruebas de Sensibilidad Microbiana , Persona de Mediana Edad , Rabeprazol , Estadísticas no Paramétricas
11.
Prikl Biokhim Mikrobiol ; 41(6): 652-5, 2005.
Artículo en Inglés | MEDLINE | ID: mdl-16358755

RESUMEN

The dynamics of tea catechins and organic acids in fermented fluid and yeast cells were studied. The concentration of eight kinds of catechins solution decreased by from 29.6% to 47.6%, respectively, some catechins were absorbed and accumulated by yeast cells, but the amount in the cells was very low during the fermentation process. The investigation of catechins resolved in four citrate buffers with a pH range of 2.6-5.6 for 18 h showed that most catechins were stable in buffer solutions of pH 4.6 and 5.6, and significant losses took place in solutions of pH 2.6 and 3.6. However, most catechins were released and recovered by adjusting the pH value to 5.6, which suggested that catechins in extremely acidic buffer solutions might reversibly combine each other or with other compounds.


Asunto(s)
Camellia sinensis/metabolismo , Catequina/biosíntesis , Fermentación , Saccharomycetales/metabolismo , Camellia sinensis/microbiología , Cromatografía Líquida de Alta Presión , Concentración de Iones de Hidrógeno , Extractos Vegetales/metabolismo
12.
Aliment Pharmacol Ther ; 16(4): 793-8, 2002 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-11929398

RESUMEN

AIM: To test the efficacy of omeprazole, furazolidone and amoxicillin triple therapy for the treatment of Helicobacter pylori infection after failure of standard first-line therapy recommended by the Asia-Pacific Consensus on the management of H. pylori infection. METHODS: Patients with failed H. pylori eradication received omeprazole, 20 mg, furazolidone, 100 mg, and amoxicillin, 1 g, all twice daily for 1 week. Endoscopy (CLO test, histology and culture) was performed before treatment. Post-treatment H. pylori status was determined by 13C-urea breath test 6 weeks later. RESULTS: Fifty patients were recruited. Resistance to metronidazole, clarithromycin and both drugs was in the range of 50-64%, 60-75% and 40-50%, respectively, after failure of first-line therapy. Amoxicillin resistance was not found. The intention-to-treat and per protocol H. pylori eradication rates were 52% and 53%, respectively. Patients with double resistance to metronidazole and clarithromycin showed the lowest eradication rate (38%), which was significantly lower than that of patients with sensitive strains (88%). Side-effects were minimal and compliance was excellent (98%). CONCLUSIONS: One-week omeprazole, furazolidone and amoxicillin rescue therapy achieved a high eradication rate in strains sensitive to metronidazole and clarithromycin. This is a cheap and safe rescue regimen when guided by pre-treatment sensitivity testing.


Asunto(s)
Amoxicilina/uso terapéutico , Antiinfecciosos Locales/uso terapéutico , Antiulcerosos/uso terapéutico , Furazolidona/uso terapéutico , Infecciones por Helicobacter/tratamiento farmacológico , Helicobacter pylori/efectos de los fármacos , Omeprazol/uso terapéutico , Adulto , Anciano , Amoxicilina/administración & dosificación , Antiinfecciosos Locales/administración & dosificación , Antiulcerosos/administración & dosificación , Farmacorresistencia Bacteriana Múltiple , Quimioterapia Combinada , Femenino , Furazolidona/administración & dosificación , Infecciones por Helicobacter/diagnóstico , Infecciones por Helicobacter/microbiología , Humanos , Masculino , Pruebas de Sensibilidad Microbiana , Persona de Mediana Edad , Omeprazol/administración & dosificación , Proyectos Piloto , Insuficiencia del Tratamiento
13.
Circ Res ; 89(4): 317-22, 2001 Aug 17.
Artículo en Inglés | MEDLINE | ID: mdl-11509447

RESUMEN

The pathogenesis of salt-sensitive hypertension remains poorly defined, but a role for nitric oxide (NO) has been suggested. The Dahl/Rapp salt-sensitive rat possesses a defect in NO synthesis that is overcome by supplementation with L-arginine, which increases NO and cGMP production and prevents salt-sensitive hypertension. An S714P mutation of inducible NO synthase (NOS2) was subsequently identified. The current report examined the functional significance of an S714P mutation in NOS2. COS-7 cells were transiently transfected with cDNA of wild-type NOS2 and S714P and S714A mutants of NOS2, and enzyme function was determined. Whereas steady-state mRNA levels did not differ, immunoblot analysis demonstrated decreased levels of NOS2 protein. Metabolic labeling experiments confirmed a reduced half-life of the S714P mutation. Nitrite production, which was dependent on the concentration of L-arginine in the medium, was diminished in cells transfected with the S714P mutant, compared with the wild type and the S714A mutant. These data provide a biochemical explanation of the physiological abnormalities of NOS2 in the Dahl/Rapp salt-sensitive rat and suggest that a posttranslational mechanism involving the proteasome may be responsible for the diminished NO production observed in response to increased dietary salt intake in these animals.


Asunto(s)
Estabilidad de Enzimas/genética , Hipertensión/enzimología , Mutación , Óxido Nítrico Sintasa/genética , Óxido Nítrico Sintasa/metabolismo , Sustitución de Aminoácidos , Animales , Arginina/metabolismo , Northern Blotting , Células COS/efectos de los fármacos , Cisteína Endopeptidasas/metabolismo , Activación Enzimática/efectos de los fármacos , Hipertensión/genética , Immunoblotting , Lactonas/farmacología , Complejos Multienzimáticos/antagonistas & inhibidores , Complejos Multienzimáticos/metabolismo , Mutagénesis Sitio-Dirigida , Óxido Nítrico/metabolismo , Óxido Nítrico Sintasa de Tipo II , Nitritos/metabolismo , Complejo de la Endopetidasa Proteasomal , Procesamiento Proteico-Postraduccional , Inhibidores de la Síntesis de la Proteína/farmacología , ARN Mensajero/metabolismo , Ratas , Ratas Endogámicas Dahl , Relación Estructura-Actividad , Transfección
14.
Biofactors ; 12(1-4): 243-50, 2000.
Artículo en Inglés | MEDLINE | ID: mdl-11216492

RESUMEN

Epidemiological studies show that postmenopausal women who undertake estrogen-replacement therapy have significantly lower risk for the onset of Alzheimer's disease (AD) than women who do not. Animal behavior studies have shown that ovariectomy results in the development of cognitive dysfunction that is prevented by estrogen-replacement, suggesting that normal mammalian cognitive function is impaired by estrogen reduction. Soy isoflavones in particular genistein have been demonstrated to have weak and selective estrogenic actions in various models of human chronic diseases. A hallmark of several human dementias including AD and fronto temporal dementia with Parkinsonism on chromosome 17 (FTDP-17) is the hyperphosphorylation of the microtubule-associated protein tau. Preliminary experiments are discussed here which show that isoflavones delivered in a soy protein matrix attenuated selected AD-relevant tau phosphorylations in a primate model of menopause. The rationale is discussed for the use of soy-based foods for protection against postmenopausal neurodegeneration.


Asunto(s)
Encéfalo/metabolismo , Proteínas en la Dieta/uso terapéutico , Proteínas del Tejido Nervioso/metabolismo , Enfermedades Neurodegenerativas/prevención & control , Proteínas de Soja/uso terapéutico , Enfermedad de Alzheimer/prevención & control , Animales , Encéfalo/efectos de los fármacos , Proteínas en la Dieta/administración & dosificación , Estrógenos/farmacología , Estrógenos/uso terapéutico , Femenino , Genisteína/administración & dosificación , Genisteína/farmacología , Genisteína/uso terapéutico , Humanos , Macaca fascicularis , Fármacos Neuroprotectores/uso terapéutico , Posmenopausia , Proteínas de Soja/administración & dosificación , Proteínas tau/metabolismo
16.
J Biol Chem ; 274(21): 14875-83, 1999 May 21.
Artículo en Inglés | MEDLINE | ID: mdl-10329687

RESUMEN

We have cloned the human Na+-dependent multivitamin transporter (SMVT), which transports the water-soluble vitamins pantothenate, biotin, and lipoate, from a placental choriocarcinoma cell line (JAR). The cDNA codes for a protein of 635 amino acids with 12 transmembrane domains and 4 putative sites for N-linked glycosylation. The human SMVT exhibits a high degree of homology (84% identity and 89% similarity) to the rat counterpart. When expressed in HRPE cells, the cDNA-induced transport process is obligatorily dependent on Na+ and accepts pantothenate, biotin, and lipoate as substrates. The relationship between the cDNA-specific uptake rate of pantothenate or biotin and Na+ concentration is sigmoidal with a Na+:vitamin stoichiometry of 2:1. The human SMVT, when expressed in Xenopus laevis oocytes, induces inward currents in the presence of pantothenate, biotin, and lipoate in a Na+-, concentration-, and potential-dependent manner. We also report here on the structural organization and chromosomal localization of the human SMVT gene. The SMVT gene is approximately 14 kilobase pairs in length and consists of 17 exons. The SMVT gene is located on chromosome 2p23 as evidenced by somatic cell hybrid analysis and fluorescence in situ hybridization.


Asunto(s)
Proteínas Portadoras/genética , Glicoproteínas de Membrana/genética , Simportadores , Secuencia de Aminoácidos , Animales , Secuencia de Bases , Transporte Biológico Activo , Biotina/metabolismo , Proteínas Portadoras/biosíntesis , Proteínas Portadoras/aislamiento & purificación , Coriocarcinoma , Mapeo Cromosómico , Clonación Molecular , ADN Complementario/genética , Femenino , Humanos , Glicoproteínas de Membrana/biosíntesis , Glicoproteínas de Membrana/aislamiento & purificación , Datos de Secuencia Molecular , Ácido Pantoténico/metabolismo , Placenta , Células Tumorales Cultivadas , Neoplasias Uterinas , Xenopus laevis
17.
Carcinogenesis ; 19(8): 1357-60, 1998 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-9744529

RESUMEN

Curcumin (diferuloylmethane), the major yellow pigment in turmeric, has been shown to inhibit benzo[a]pyrene (BaP)-induced forestomach cancer in mice through mechanism(s) not fully understood. It is well known that while cytochrome P4501A1 (CYP1A1) and epoxide hydrolase (EH) are important in the conversion of BaP to its activated form, (+)-anti-7,8-dihydroxy-9,10-oxy-7,8,9,10-tetrahydrobenzo[a]pyrene [(+)-anti-BaPDE], the detoxification of (+)-anti-BaPDE is accomplished by glutathione (GSH) S-transferases (GST). Therefore, it seems reasonable to postulate that curcumin may exert anti-carcinogenic activity either by inhibiting activation of BaP or (and) by enhancing the detoxification of (+)-anti-BaPDE. Administration p.o. of 2% curcumin in the diet to female A/J mice for 14 days, which has been shown to cause a significant inhibition in BaP-induced forestomach tumorigenesis, resulted in a modest but statistically significant reduction in hepatic ethoxyresorufin O-deethylase (EROD) activity, a reaction preferentially catalyzed by CYP1A1. While EROD activity could not be detected in the forestomach of either control or treated mice, curcumin feeding caused a statistically significant increase (approximately 2.3-fold) in hepatic EH and GST activities. Hepatic and forestomach GSH levels, and forestomach EH and GST activities were not affected by curcumin treatment. Even though the levels of various hepatic GST isoenzymes were significantly increased upon curcumin feeding, maximum induction was noticed for the pi class isoenzyme (mGSTP1-1), which among murine hepatic GSTs is highly efficient in the detoxification of (+)-anti-BaPDE. In conclusion, the results of the present study suggest that curcumin may inhibit BaP-induced forestomach cancer in mice by affecting both activation as well as inactivation pathways of BaP metabolism in the liver.


Asunto(s)
Antineoplásicos/uso terapéutico , Curcumina/uso terapéutico , Citocromo P-450 CYP1A1/efectos de los fármacos , Neoplasias Gástricas/prevención & control , Animales , Benzo(a)pireno/metabolismo , Carcinógenos/metabolismo , Citocromo P-450 CYP1A1/metabolismo , Ensayos de Selección de Medicamentos Antitumorales , Epóxido Hidrolasas/metabolismo , Femenino , Glutatión/metabolismo , Gutatión-S-Transferasa pi , Glutatión Transferasa/metabolismo , Isoenzimas/metabolismo , Ratones , Neoplasias Gástricas/inducido químicamente , Neoplasias Gástricas/metabolismo
18.
J Allergy Clin Immunol ; 101(3): 354-62, 1998 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-9525452

RESUMEN

BACKGROUND: Human basophils are difficult to detect with classic histochemical stains at sites of allergic inflammation. The 2D7 anti-basophil monoclonal antibody was used to identify basophils in skin during the late-phase response to a cutaneous allergen challenge. METHODS: The 2D7 monoclonal antibody was used on protease-digested sections of skin biopsy specimens obtained 6 and 24 hours after an allergen or buffer challenge. The skin chamber technique was used to compare buffer- and allergen-challenged sites at 6 hours, and intradermal injection of allergen was used to compare allergen-challenged sites at 6 and 24 hours. RESULTS: Dramatic increases in the numbers of 2D7+ cells and in tissue staining by 2D7 were observed 6 hours after allergen challenge compared with buffer challenge. Histamine levels in skin chamber fluid varied with 2D7+ cell concentrations. By 24 hours, 2D7+ cells and tissue staining appeared to diminish but were still detectable in the allergen-challenged sites. Basophils localized primarily in and around blood vessels, whereas mast cells remained mostly in the superficial dermis. Mast cells were 2D7- in both the allergen- and buffer-challenged skin. Metachromatic staining of 2D7+ basophils with toluidine blue was absent in these tissue sections. CONCLUSIONS: The 2D7 monoclonal antibody provides a more sensitive and precise marker than histochemical staining for human basophil involvement during the late-phase response to an allergen challenge. Basophil infiltration was observed at 6 hours only after allergen challenge and persisted at similar levels by 24 hours.


Asunto(s)
Basófilos/inmunología , Dermatitis Atópica/inmunología , Inmunohistoquímica/métodos , Piel/inmunología , Alérgenos/inmunología , Animales , Anticuerpos Monoclonales/inmunología , Basófilos/metabolismo , Biopsia , Vasos Sanguíneos/inmunología , Dermatitis Atópica/metabolismo , Endopeptidasas/inmunología , Endopeptidasas/farmacología , Histamina/análisis , Histamina/metabolismo , Histocitoquímica , Humanos , Mastocitos/inmunología , Ratones , Poaceae/inmunología , Polen/inmunología , Piel/metabolismo , Pruebas Cutáneas
19.
Biochem Biophys Res Commun ; 244(3): 917-20, 1998 Mar 27.
Artículo en Inglés | MEDLINE | ID: mdl-9535768

RESUMEN

This study was undertaken to elucidate the mechanism of organ specificity and differential efficacy of garlic organosulfides (OSCs) [diallyl sulfide (DAS), diallyl disulfide (DADS), diallyl trisulfide (DATS), dipropyl sulfide (DPS) and dipropyl disulfide (DPDS)] in preventing benzo(a)pyrene (BP)-induced tumorigenesis in mice. The results of the present study reveal a good correlation between chemopreventive efficacies of garlic OSCs and their inductive effects on the expression of NAD(P)H:quinone oxidoreductase (NQO), an enzyme implicated in the detoxification of activated quinone metabolites of BP. Treatment of mice with DADS and DATS, which are potent inhibitors of BP-induced forestomach tumorigenesis, resulted in a statistically significant increase (2.4- and 1.5-fold, respectively) in forestomach NQO activity. In addition, DADS and DATS were much more potent inducers of forestomach NQO activity than DAS, which is a weak inhibitor of BP-induced forestomach tumorigenesis than the former compounds. Propyl-group containing OSCs (DPS and DPDS), which do not inhibit BP-induced tumorigenesis, did not affect forestomach NQO activity. Similar to forestomach, a good correlation was also observed between effects of these OSCs against BP-induced pulmonary tumorigenesis and their effects on NQO expression in the lung. For example, treatment of mice with DAS, which is a potent inhibitor of BP-induced pulmonary tumorigenesis, resulted in about 3.2-fold increase in pulmonary NQO activity. On the other hand, this activity was increased by about 1.5-fold upon DATS administration, which does not inhibit BP-induced cancer of the lung. In conclusion, our results suggest that induction of NQO may be important in anti-cancer effects of garlic OSCs.


Asunto(s)
Compuestos Alílicos/farmacología , Anticarcinógenos/farmacología , Ajo/química , NAD(P)H Deshidrogenasa (Quinona)/biosíntesis , Plantas Medicinales , Sulfuros/farmacología , Animales , Benzo(a)pireno/farmacología , Carcinógenos/farmacología , Disulfuros/farmacología , Inducción Enzimática/efectos de los fármacos , Femenino , Pulmón/enzimología , Ratones , Propano/análogos & derivados , Propano/farmacología , Estómago/enzimología , Relación Estructura-Actividad
20.
Int J Cancer ; 73(6): 897-902, 1997 Dec 10.
Artículo en Inglés | MEDLINE | ID: mdl-9399673

RESUMEN

There is a growing need for short-term and cost-effective bioassay to assess the efficacy of potential chemo-preventive agents. We report that the induction of glutathione (GSH) S-transferase pi (mGSTP1-1) by a chemo-preventive agent can be used as a reliable marker to assess its efficacy in retarding chemical carcinogenesis induced by benzo(a)pyrene (BP), which is a widespread environmental pollutant and believed to be a risk factor in human chemical carcinogenesis. This conclusion is based on 1) the relative contribution of mGSTP1-1 of the liver and forestomach of female A/J mice in the detoxification of the ultimate carcinogenic metabolite of BP, (+)-anti-7,8-dihydroxy-9, 10-oxy-7,8,9, 10-tetrahydrobenzo(a)pyrene [(+)-anti-BPDE]; and 2) a positive correlation between the induction of hepatic and forestomach mGSTP1-1 by 5 naturally occurring organosulfides (OSCs) from garlic (diallyl sulfide, diallyl disulfide, diallyl trisulfide, dipropyl sulfide and dipropyl disulfide) and their effectiveness in preventing BP-induced forestomach neoplasia in mice. In the liver, the combined contribution of other GSTs in the detoxification of (+)-anti-BPDE was far less than the contribution of mGSTP1-1 alone. Likewise, in the forestomach, the contribution of mGSTP1-1 far exceeded the combined contribution of other GSTs. Studies on the effects of OSCs against BP-induced forestomach neoplasia revealed a good correlation between their chemo-preventive efficacy and their ability to induce mGSTP1-1 expression in the liver (r = -0.89; p < 0.05) as well as in the forestomach (r = -0.97; p < 0.05). Our results suggest that the induction of mGSTP1-1 may be a reliable marker for evaluating the efficacy of potential inhibitors of BP-induced cancer in a murine model.


Asunto(s)
Anticarcinógenos/uso terapéutico , Benzo(a)pireno/toxicidad , Glutatión Transferasa/biosíntesis , Isoenzimas/biosíntesis , Neoplasias Gástricas/prevención & control , Sulfuros/uso terapéutico , Compuestos Alílicos/aislamiento & purificación , Compuestos Alílicos/uso terapéutico , Animales , Anticarcinógenos/aislamiento & purificación , Bioensayo/economía , Bioensayo/métodos , Cromatografía Líquida de Alta Presión , Disulfuros/aislamiento & purificación , Disulfuros/uso terapéutico , Inducción Enzimática , Femenino , Ajo/química , Gutatión-S-Transferasa pi , Glutatión Transferasa/metabolismo , Isoenzimas/metabolismo , Hígado/enzimología , Ratones , Ratones Endogámicos A , Plantas Medicinales , Propano/análogos & derivados , Propano/aislamiento & purificación , Propano/uso terapéutico , Análisis de Regresión , Estómago/enzimología , Neoplasias Gástricas/inducido químicamente , Neoplasias Gástricas/enzimología , Sulfuros/aislamiento & purificación , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA